CClinicalTrials.gg
CompletedNCT03303404Updated Dec 22, 2020Results posted

24-hour Blood Pressure Measurements and Ischemic Conditioning

An interventional study of Ambulatory (24-hour) Blood Pressure in Blood Pressure, sponsored by University of Texas at Austin. Completed at 1 site in United States. Open to participants aged 30 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-12-22.

Sponsored by University of Texas at Austin · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
22
Allocation
Not applicable
Ages
30 Years to 60 Years
Sex
All
01

Study summary

To determine if 24-hr ambulatory blood pressure monitoring effects endothelial function, we will measure flow-mediated dilation before and after the blood pressure monitoring (ischemia conditioning).

Read the detailed description

Reestablishing blood flow (reperfusion) to organs that had their blood supply restricted (ischemia) can cause damage to the vasculature via injury and tissue death resulting in endothelial dysfunction. This ischemia-reperfusion (blood flow occlusion and resupply) triggered injury can be reduced or prevented by preceding brief periods of ischemia called preconditioning. Properly-performed preconditioning can exert a powerful protection against a subsequent sustained period of ischemia in a variety of organs in the body including the heart, kidney, and skeletal muscle. Preconditioning protocol involves repeated brief inflation and deflation of a blood pressure cuff. In many of human cardiovascular research studies, it is common to measure endothelial function and ambulatory (24-hour) blood pressure. The ambulatory blood pressure device takes repeated blood pressure readings every 15-30 minutes during the daytime and 30-60 minutes at night. It is possible that repeated bouts of inflation/deflation of the blood pressure cuff could induce preconditioning effects and influence endothelial function. Therefore, in the proposed study we aim to address this hypothesis.

02

Conditions studied

  • Blood Pressure
03

Who can participate

Ages eligible
30 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

Adults aged between 30 to 60 years old.

Exclusion criteria

Exclusion Criteria:

Exclusion from the study may be due to: i) pregnancy (by asking the subjects when the last time she had menstruation; we do have simple testing kits available if a subject is unsure about her status); ii) a recent illness, recent surgery, or any medical intervention in the 48 hours before any of the study days; iii) personal history of diabetes (fasting blood glucose > 126 mg/dL), heart disease, or other cardiovascular problems.

04

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
22 participants (actual)

Study arms

  • Experimental
    Ambulatory (24-hour) Blood Pressure

    Device: Ambulatory (24-hour) Blood Pressure

Interventions

  • DeviceAmbulatory (24-hour) Blood Pressure

    Unlike casual blood pressure measurements, 24-hour ambulatory blood pressure monitoring provides an insight into blood pressure changes in everyday life and an estimate of the overall blood pressure load exerted on the cardiovascular system over 24 hours. Blood pressure recordings over a 24-hour period of normal daily activity will be made using a noninvasive ambulatory monitor (Spacelabs, Redlands, WA). The ambulatory system will be calibrated against a mercury sphygmomanometer, and the cuff will be programmed to inflate automatically every 15 min from 6 AM to 11 PM and every 20 min between 11 PM and 6 AM. For each individual subject, the nighttime period will be defined as the time when the subject goes to bed at night until rising in the morning. Daytime will be defined as the remainder of the 24-hour period. Daytime and nighttime states will be monitored by an Actiwatch (Mini-MItter, Bend, OR), a watch-like device placed on the wrist that measures gross motor activity.

05

What researchers measure

Primary outcomes

  1. Change From Baseline in Flow Mediated Dilation After 24 Hour Ischemic Conditioning With Blood Pressure Cuff

    Flow-mediated dilatation (FMD) is a common and non-invasive method to assess vascular endothelial function by measuring the Brachial artery's responsiveness (diameter percent increase) following a brief period of occlusion.

    Time frame: Baseline, Post 24 hour conditioning

06

Results

Posted Dec 22, 2020

Participant flow

Participant flow — Overall Study
MilestoneAmbulatory (24-hour) Blood Pressure
Started22
Completed22
Not completed0

Outcome measures

PrimaryChange From Baseline in Flow Mediated Dilation After 24 Hour Ischemic Conditioning With Blood Pressure Cuff

Flow-mediated dilatation (FMD) is a common and non-invasive method to assess vascular endothelial function by measuring the Brachial artery's responsiveness (diameter percent increase) following a brief period of occlusion.

Time frame:
Baseline, Post 24 hour conditioning
Reported as:
Mean · percentage of baseline
Change From Baseline in Flow Mediated Dilation After 24 Hour Ischemic Conditioning With Blood Pressure Cuff
percentage of baselineIntervention
Change From Baseline in Flow Mediated Dilation After 24 Hour Ischemic Conditioning With Blood Pressure Cuff6.6 ± 2.0

Adverse events

Collected over 6 months. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Intervention0/22 (0%)0/22 (0%)0/22 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Ambulatory (24-hour) Blood Pressure
<=18 years0
Between 18 and 65 years22
>=65 years0
Age, Continuous
Age, Continuous(years)Ambulatory (24-hour) Blood Pressure
Mean41 ± 8
Sex: Female, Male
Sex: Female, Male(Participants)Ambulatory (24-hour) Blood Pressure
Female10
Male12
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Ambulatory (24-hour) Blood Pressure
American Indian or Alaska Native0
Asian8
Native Hawaiian or Other Pacific Islander0
Black or African American0
White14
More than one race0
Unknown or Not Reported0
Region of Enrollment
Region of Enrollment(participants)Ambulatory (24-hour) Blood Pressure
United States22
07

Study locations

1 site
  • Dr. Hirofumi Tanaka
    Austin, Texas 78713, United States
08

References and documents

Publications

  • Fico BG, Zhu W, Tanaka H. Does 24-h ambulatory blood pressure monitoring act as ischemic preconditioning and influence endothelial function? J Hum Hypertens. 2019 Nov;33(11):817-820. doi: 10.1038/s41371-019-0214-y. Epub 2019 Jun 27. PubMed 31249371 ↗

Study documents

  • Protocol and statistical analysis plan · Sep 12, 2017

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Registry details

Key details

Study ID
NCT03303404
Lead sponsor
University of Texas at Austin
Responsible party
Sponsor
First posted
Oct 6, 2017
Start date
Sep 12, 2017
Primary completion
Sep 20, 2018
Completion
Sep 20, 2018
Results posted
Dec 22, 2020
Last update
Dec 22, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion